Peer Review History
| Original SubmissionJune 13, 2025 |
|---|
|
Dear Dr. Schlatt, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Oct 06 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Su-Ren Chen Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following financial disclosure: “Funding for instrumentation: Zeiss LSM 980: INST 211/898-1 FUGB, Confocal Laser Scanning Microscope. Miltenyi TriMScope II: INST 211/900-1 FUGB, Multiphoton Microscope Miltenyi UltraMicroscope II Super Plan: INST 211/899-1 FUGB, Light Sheet Microscope Deutsche Forschungsgemeinschaft (DFG): CRU326.” Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 3. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Please carefully revise the manuscript according to two reviewers' comments and I am looking forwards to receiving the revision. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: N/A Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: The study introduces an innovative method (PT-CLEAR3D) for tissue clearing and 3D imaging, enabling detailed analysis of spatial organization and cellular interactions within intact primate testes. This approach marks a significant advancement in the investigation of testicular physiology and pathophysiology, overcoming key limitations of conventional histology. The manuscript is generally well-structured and clearly written, and the methodology is described in detail. Nevertheless, the manuscript would benefit from additional clarification. Below are my comments and revision requests: 1.The authors state (line 406): “However, after subsequently incubating the same ITTs in BABB, complete clearing was attained, as confirmed by the visibility of the grids through the tissues, which enabled tissue imaging thereafter.” From this description, it appears that the main limitation of the commercial kit lies in the refractive index (RI) matching medium, rather than the overall protocol. To help clarify this point and also to strengthen the evidence that PT-CLEAR3D performs better than the commercial kit, the manuscript would benefit from: representative LSFM images from samples processed with both PT-CLEAR3D and the commercial kit; quantitative assessment of signal-to-noise (S/N) and signal-to-background (S/B) ratios in both cases and a brief discussion of labeling specificity in both cases. 2.Since the tissues analyzed were unusually thick (from 0.5 to 50 mm³), signal attenuation and degradation at depth may significantly affect imaging quality. I recommend the authors provide representative images acquired at multiple z-positions (e.g., 50 µm, 100 µm, 200 µm, etc.) for human, marmoset, and macaque testes samples. This would demonstrate labeling uniformity throughout the depth of the section. Please also comment explicitly on whether signal intensity decreases with depth and indicate any correction methods used (e.g., deconvolution, intensity normalization). 3.For all figures with fluorescent images, please specify: the thickness of the imaged samples and whether the displayed images are maximum intensity projections (MIPs) or single optical sections. This information is essential for readers to correctly interpret resolution and signal fidelity. 4.The manuscript mentions the use of Arivis Pro TileSorter for manual stitching. Please provide more details such as the percentage of image overlaps used and how registration errors were corrected. This will improve reproducibility. 5.Please provide 1–2 sentences describing sample mounting/orientation during LSFM imaging (cuvette? Chamber? Suspended?) and explicitly state the immersion medium used. Confirm that the objectives were corrected for the BABB refractive index. Reviewer #2: Traditional 3D tissue analysis using fluorescence microscopy relies on aligning serial sections, which is computationally intensive and prone to artefacts, or imaging of whole mounts with limited imaging depth. Optical clearing combined with light sheet fluorescence microscopy (LSFM) enables imaging of intact tissues while preserving 3D architecture. Although optical clearing has been optimised for many tissues, primate testis tissue remains a challenge due to its dense cellular structure. This study presents an optimised clearing method for primate testis, PT-CLEAR3D, benchmarked against a commercial clearing kit and traditional confocal microscopy of sliced tissues. The approach enables more detailed structural analysis of testis tissue and will facilitate significant advancements for the field. I believe this paper is worthy of publication, but I offer the following suggestions to strengthen it: 1. PT-CLEAR3D was tested only against one commercial solvent-based kit, not against widely used methods such as DISCO, or other BABB protocols. This limitation should either be noted, or additional comparisons included. 2. Line 366 – PTMCs are not introduced; please define. 3. Line 404 – Clarify that the commercial kit was inefficient specifically for testis tissue, not in general. 4. Figures 1A, 1E, 3A – Fluorescence LUTs should be more distinct; magenta is visually too close to red and should be replaced with e.g. green. 5. Figure S1D – Only 5 cells appear present in the group of 8 spermatagonia cells; label individual cells within each group e.g. with asterisks. 6. Figure 7 – a. Ensure 2D and 3D images show equivalent fields of view. At present, the 2D images have a smaller field of view compared to the 3D images. b. State whether local maximum projection was used for 3D rendering, and over what range. Ensure any maximum projection processing is consistent between 2D and 3D images. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Christopher Smith ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Dear Dr. Schlatt, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Nov 26 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Su-Ren Chen Academic Editor PLOS ONE Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Reviewer 2 raises some additional minor concerns. I have to ask the authors to further revise the manuscript according to his/her suggestions. I am looking forwards to receive your final version. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #2: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: No ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: The authors have adequately addressed all the comments; therefore, no further revisions are needed on my part Reviewer #2: Thank you to the authors for thoughtfully addressing each of my previous comments. I have a couple of additional recommendations: • Lines 466–482: The purpose of this paragraph is to compare PT-CLEAR3D with the other clearing techniques and to justify why PT-CLEAR3D represents the optimal approach. However, with the inclusion of new information regarding the analysis of the different clearing techniques, as well as the clarification that the testing was conducted only on testis tissue and not on other tissue types, the concluding sentence of the paragraph now appears somewhat disjointed. I recommend revising the structure of this final paragraph to improve its coherence and logical flow. • I commend the authors for their additions in response to the first reviewer, which in my view clearly demonstrate the benefit of additional BAAB clearing following the use of the commercial clearing kit in primate testis tissue (Figs. S2–S5). However, it is unexpected that PT-CLEAR3D was omitted from this analysis. Including PT-CLEAR3D in these comparative analyses would substantially strengthen the overall message of the manuscript. • There appears to be a large standard deviation in Figs. S5 and S9. The authors should provide statistical evidence to indicate whether there are significant differences between the clearing techniques at depth. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Christopher Smith ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 2 |
|
Optical tissue clearing and 3D imaging of intact primate testicular tissue: a novel technology development PONE-D-25-22183R2 Dear Dr. Schlatt, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Su-Ren Chen Academic Editor PLOS ONE Additional Editor Comments (optional): I would like to recommend acceptance of your revised manuscript (R2). Reviewers' comments: |
| Formally Accepted |
|
PONE-D-25-22183R2 PLOS ONE Dear Dr. Schlatt, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Prof. Su-Ren Chen Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .